Inactive Instrument

Press Releases Neurotrope, Inc.

Equities

NTRP

US64129T2078

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

NEUROTROPE, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	20-11-25	AQ
NEUROTROPE, INC. : Other Events (form 8-K)	20-11-24	AQ
NEUROTROPE, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	20-11-20	AQ
NEUROTROPE : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	20-11-09	AQ
NEUROTROPE, INC. : Other Events (form 8-K)	20-09-30	AQ
NEUROTROPE, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	20-09-30	AQ
NEUROTROPE : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	20-08-10	AQ
NEUROTROPE, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	20-07-29	AQ
NEUROTROPE, INC. : Other Events (form 8-K)	20-07-24	AQ
NEUROTROPE, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	20-07-24	AQ
Neurotrope : Announces Strategic Partnership with BryoLogyx for Supply of Synthetic Bryostatin-1 and Continuation of the National Cancer Institute Trial for Childhood Leukemia	20-06-15	AQ
NEUROTROPE : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	20-06-12	AQ
NEUROTROPE, INC. : Regulation FD Disclosure, Other Events (form 8-K)	20-05-28	AQ
Neurotrope : Launches New Long-Term Clinical Trial of Bryostatin with the National Institutes of Health for the Treatment of Patients with Alzheimer’s Disease	20-05-28	PU
NEUROTROPE, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	20-05-18	AQ
NEUROTROPE, INC. : Other Events (form 8-K)	20-05-11	AQ
NEUROTROPE : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	20-03-13	AQ
NEUROTROPE, INC. : Change in Directors or Principal Officers (form 8-K)	20-02-27	AQ
NEUROTROPE, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	20-02-26	AQ
Neurotrope : Provides Corporate Update after Completing Bryostatin-1 Data Analysis for Advanced Alzheimer's disease Trial	20-01-24	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Neurotrope, Inc.

Equities

NTRP

US64129T2078

Press Releases

Filters